Reemergence of recombinant vaccine–derived poliovirus outbreak in Madagascar.
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Background After the 2001-2002 poliomyelitis outbreak due to recombinant vaccine-derived polioviruses (VDPVs) in the Toliara province of Madagascar, another outbreak reoccurred in the same province in 2005. Methods We conducted epidemiological and virological investigations for each polio case patient and for their contacts. Results From May to August 2005, a total of 5 cases of acute flaccid paralysis were reported among unvaccinated or partially vaccinated children 2-3 years old. Type-3 or type-2 VDPV was isolated from case patients and from healthy contacts. These strains were classified into 4 recombinant lineages that showed complex mosaic genomic structures originating from different vaccine strain serotypes and probably from human enterovirus C (HEV-C) species. Genetic relatedness could be observed among these 4 lineages. Vaccination coverage of the population was very low ( Conclusions The broad distribution of VDPVs in the province and their close genetic relationship indicate intense and rapid cocirculation and coevolution of the vaccine strains and of their related HEV-C strains. The occurrence of an outbreak due to VDPV 3 years after a previous outbreak indicates that a short period with low vaccination coverage is enough to create favorable conditions for the emergence of VDPV in this setting.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These VDPVs were found in patients with acute flaccid paralysis (AFP) and in healthy children who were contacts of the patients with AFP (2,4).”
From Reemergence of Recombinant Vaccine–derived Polioviruses in Healthy Children, Madagascar (2013) · cites this paper as [2]
In the citing paper
“Polio outbreaks associated with type 2 or 3 VDPVs (VDPV2s or VDPV3s) were reported in 2001–2002 and 2005 in Toliara Province in southern Madagascar (2,3).”
From Reemergence of Recombinant Vaccine–derived Polioviruses in Healthy Children, Madagascar (2013) · cites this paper as [2]
In the citing paper
“Nevertheless, recombination sites could be found elsewhere in the P2 or the P3 region [89,90].”
From Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence (2011) · cites this paper as [89]
In the citing paper
“All recombinant cVDPV genomes described so far had kept at least the entire region encoding the capsid proteins of OPV strains (with more than 1% nt substitutions), and some or all of the rest of the genome, particularly the region encoding non-structural proteins, originates from other HEV-Cs [67,83,84,88–90].”
From Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence (2011) · cites this paper as [89]
In the citing paper
“In addition, many type 2 VDPV lineages displayed a great part of their 5′NC region derived from non-OPV HEV-Cs.”
From Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence (2011) · cites this paper as [89]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227
Kishino, H., & Hasegawa, M. (1989) · Journal of Molecular Evolution · doi:10.1007/bf02100115 · Cited by 3,373
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION
Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., & Pallansch, M. A. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123625 · Cited by 703
Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J., Jorba, J., et al. (2002) · Science · doi:10.1126/science.1068284 · Cited by 600 · cited 1×
“cVDPV were reported in Haiti and the Dominican Republic, the Philippines, Madagascar, China, Cambodia, and Indonesia [8-12].”
BackgroundCirculating vaccine-derived polioviruses: current state of knowledge.
Kew, O. M., Wright, P. F., Agol, V. I., Delpeyroux, F., Shimizu, H., Nathanson, N., & Pallansch, M. A. (2004) · PubMed · doi:10.1590/s0042-96862004000100006 · Cited by 258
Self-citationFine, P. E. M., & Carneiro, I. A. M. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009924 · Cited by 247
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993
Yang, C.-F., Naguib, T., Yang, S.-J., Nasr, E., Jorba, J., Ahmed, N., Campagnoli, R., van der Avoort, H., Shimizu, H., Yoneyama, T., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8366-8377.2003 · Cited by 233
Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient
Kew, O. M., Sutter, R. W., Nottay, B. K., McDonough, M. J., Prevots, D. R., Quick, L., & Pallansch, M. A. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.10.2893-2899.1998 · Cited by 213 · cited 1×
“Some persons with humoral immunodeficiency are known to excrete modified diverse VDPV strains for prolonged periods (5–12 years) [33, 34], compared with immunocompetent individuals.”
BackgroundSimmonds, P. (2006) · Journal of Virology · doi:10.1128/jvi.01076-06 · Cited by 204 · cited 1×
“Rapid evolution by recombination has also been described for HEV-B species [30, 31], for wild polioviruses [5], and for OPV strains [3].”
BackgroundNatural genetic exchanges between vaccine and wild poliovirus strains in humans.
Guillot, S., Caro, V., Cuervo, N., Korotkova, E., Combiescu, M., Persu, A., Aubert-Combiescu, A., Delpeyroux, F., & Crainic, R. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8434-8443.2000 · Cited by 202
Self-citation
Research works printed but not linked: 4
- Centers, 2006, MMWR Morb Mortal Wkly Rep, 55, 458
- Zimmerman RK, 1999, Am Fam Physician, 59, 113
- Kew OM, 2004, Bull World Health Organ, 82, 16
- Centers, 2006, MMWR Morb Mortal Wkly Rep, 55, 1093
Cited by
Role of environmental poliovirus surveillance in global polio eradication and beyond
HOVI, T., SHULMAN, L. M., VAN DER AVOORT, H., DESHPANDE, J., ROIVAINEN, M., & DE GOURVILLE, E. M. (2012) · Epidemiology and Infection · doi:10.1017/s095026881000316x · Cited by 318
“Recent circulating VDPV (cVDPV) outbreaks have, however, raised concern that, under certain circumstances, especially following decreased OPV coverage [28], the OPV strains have the potential to cause sustained transmission and paralytic disease [29–39].”
BackgroundBurns, C. C., Diop, O. M., Sutter, R. W., & Kew, O. M. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu295 · Cited by 309
A systematic approach to virus–virus interactions
DaPalma, T., Doonan, B. P., Trager, N. M., & Kasman, L. M. (2010) · Virus Research · doi:10.1016/j.virusres.2010.01.002 · Cited by 273
Huang, S.-W., Hsu, Y.-W., Smith, D. J., Kiang, D., Tsai, H.-P., Lin, K.-H., Wang, S.-M., Liu, C.-C., Su, I.-J., & Wang, J.-R. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00630-09 · Cited by 190
Sutter, R. W., Kew, O. M., & Cochi, S. L. (2008) · Vaccines · doi:10.1016/b978-1-4160-3611-1.50030-1 · Cited by 167
Emerging Viral Infections of the Central Nervous System: Part 1
Tyler, K. L. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.153 · Cited by 158
Burns, C. C., Shaw, J., Jorba, J., Bukbuk, D., Adu, F., Gumede, N., Pate, M. A., Abanida, E. A., Gasasira, A., Iber, J., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02954-12 · Cited by 153
Self-citationRecombination in Enteroviruses, a Multi-Step Modular Evolutionary Process
Muslin, C., Kain, A. M., Bessaud, M., Blondel, B., & Delpeyroux, F. (2019) · Viruses · doi:10.3390/v11090859 · Cited by 142
Self-citationCombelas, N., Holmblat, B., Joffret, M.-L., Colbère-Garapin, F., & Delpeyroux, F. (2011) · Viruses · doi:10.3390/v3081460 · Cited by 135
Self-citationWassilak, S., Pate, M. A., Wannemuehler, K., Jenks, J., Burns, C., Chenoweth, P., Abanida, E. A., Adu, F., Baba, M., Gasasira, A., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq140 · Cited by 120
Jegouic, S., Joffret, M.-L., Blanchard, C., Riquet, F. B., Perret, C., Pelletier, I., Colbere-Garapin, F., Rakoto-Andrianarivelo, M., & Delpeyroux, F. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000412 · Cited by 116
Self-citationMechanisms and consequences of positive-strand RNA virus recombination
Bentley, K., & Evans, D. J. (2018) · Journal of General Virology · doi:10.1099/jgv.0.001142 · Cited by 110
High Frequency and Diversity of Species C Enteroviruses in Cameroon and Neighboring Countries
Sadeuh-Mba, S. A., Bessaud, M., Massenet, D., Joffret, M.-L., Endegue, M.-C., Njouom, R., Reynes, J.-M., Rousset, D., & Delpeyroux, F. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02119-12 · Cited by 108
Self-citationBessaud, M., Pillet, S., Ibrahim, W., Joffret, M., Pozzetto, B., Delpeyroux, F., & Gouandjika‐Vasilache, I. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06657-11 · Cited by 105
Self-citationTebbens, R. J. D., Pallansch, M. A., Kim, J., Burns, C. C., Kew, O. M., Oberste, M. S., Diop, O. M., Wassilak, S. G. F., Cochi, S. L., & Thompson, K. M. (2013) · Risk Analysis · doi:10.1111/risa.12022 · Cited by 105
Recombination among human non-polio enteroviruses: implications for epidemiology and evolution
Kyriakopoulou, Z., Pliaka, V., Amoutzias, G. D., & Markoulatos, P. (2014) · Virus Genes · doi:10.1007/s11262-014-1152-y · Cited by 96
Muslin, C., Joffret, M., Pelletier, I., Blondel, B., & Delpeyroux, F. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005266 · Cited by 86
Self-citationSutter, R. W., Kew, O. M., Cochi, S. L., & Aylward, R. B. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00035-5 · Cited by 85
Feasibility of Quantitative Environmental Surveillance in Poliovirus Eradication Strategies
Lodder, W. J., Buisman, A., Rutjes, S. A., Heijne, J. C. M., Teunis, P. F. M., & Husman, A. D. R. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.07972-11 · Cited by 78
RNA Structures Facilitate Recombination-Mediated Gene Swapping in HIV-1
Simon‐Lorière, E., Martin, D. P., Weeks, K. M., & Negroni, M. (2010) · Journal of Virology · doi:10.1128/jvi.01302-10 · Cited by 78
Reaching the last one per cent: progress and challenges in global polio eradication
Kew, O. M. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.02.006 · Cited by 69
Estimating the Extent of Vaccine-Derived Poliovirus Infection
Wringe, A., Fine, P. E. M., Sutter, R. W., & Kew, O. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003433 · Cited by 68
Holmblat, B., Jégouic, S., Muslin, C., Blondel, B., Joffret, M., & Delpeyroux, F. (2014) · mBio · doi:10.1128/mbio.01119-14 · Cited by 62
Self-citationGenetic Relationship between Cocirculating Human Enteroviruses Species C
Bessaud, M., Joffret, M.-L., Holmblat, B., Razafindratsimandresy, R., & Delpeyroux, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024823 · Cited by 55
Self-citationBessaud, M., Joffret, M., Blondel, B., & Delpeyroux, F. (2016) · Scientific Reports · doi:10.1038/srep38831 · Cited by 53
Self-citationThe Golgi Protein ACBD3, an Interactor for Poliovirus Protein 3A, Modulates Poliovirus Replication
Téoulé, F., Brisac, C., Pelletier, I., Vidalain, P., Jégouic, S., Mirabelli, C., Bessaud, M., Combelas, N., Autret, A., Tangy, F., et al. (2013) · Journal of Virology · doi:10.1128/jvi.00304-13 · Cited by 52
Self-citationZhang, T., Du, J., Xue, Y., Su, H., Yang, F., & Jin, Q. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067157 · Cited by 51
Genetic diversity and C2-like subgenogroup strains of enterovirus 71, Taiwan, 2008
Huang, Y.-P., Lin, T., Hsu, L., Chen, Y., Tseng, Y.-H., Hsu, C.-C., Fan, W.-B., Yang, J., Chang, F., & Wu, H.-S. (2010) · Virology Journal · doi:10.1186/1743-422x-7-277 · Cited by 45
Joffret, M.-L., Jégouic, S., Bessaud, M., Balanant, J., Tran, C., Caro, V., Holmblat, B., Razafindratsimandresy, R., Reynes, J.-M., Rakoto-Andrianarivelo, M., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis204 · Cited by 44
Self-citationXu, W., & Zhang, Y. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-3292-4_10 · Cited by 40
Multiple recombinants in two dengue virus, serotype-2 isolates from patients from Oaxaca, Mexico
Pérez‐Ramírez, G., Díaz-Badillo, Á., Camacho-Nuez, M., Cisneros, A., & Muñoz, M. D. L. (2009) · BMC Microbiology · doi:10.1186/1471-2180-9-260 · Cited by 38
Reduced Poliovirus vaccine neutralising-antibody titres in infants with maternal HIV-exposure
Sanz-Ramos, M., Manno, D., Kapambwe, M., Ndumba, I., Musonda, K. G., Bates, M., Chibumbya, J. N., Siame, J., Monze, M., Filteau, S., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.02.044 · Cited by 35
Zhang, Y., Yan, D., Zhu, S., Wen, N., Li, L., Wang, H., Liu, J., Ye, X., Ding, Z., Wang, D., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/657410 · Cited by 35
The Fight against Poliovirus Is Not Over
Mbani, C. J., Nekoua, M. P., Moukassa, D., & Hober, D. (2023) · Microorganisms · doi:10.3390/microorganisms11051323 · Cited by 34
The risk of type 2 oral polio vaccine use in post-cessation outbreak response
McCarthy, K. A., Chabot‐Couture, G., Famulare, M., Lyons, H. M., & Mercer, L. D. (2017) · BMC Medicine · doi:10.1186/s12916-017-0937-y · Cited by 33
Sutter, R. W., Kew, O. M., Cochi, S. L., & Aylward, R. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00048-1 · Cited by 33
Adeniji, J. A., & Faleye, T. O. C. (2015) · Archives of Virology · doi:10.1007/s00705-014-2322-x · Cited by 29
Yan, D., Li, L., Zhu, S., Zhang, Y., An, J., Wang, D., Wen, N., Jorba, J. C., Liu, W. Y., Zhong, G., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00712-10 · Cited by 28
Detection of Vaccine-Derived Polioviruses in Mexico Using Environmental Surveillance
Esteves-Jaramillo, A., Estívariz, C. F., Peñaranda, S., Richardson, V., Reyna, J., Coronel, D. L., Carrion, V., Landaverde, M., Wassilak, S. G. F., Pérez-Sánchez, E. E., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu183 · Cited by 27
Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria
Giwa, F., Olayinka, A., & Ogunshola, F. T. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.09.023 · Cited by 26
Zhang, Y., Yan, D., Zhu, S., Nishimura, Y., Ye, X., Wang, D., Jorba, J. C., Zhu, H., An, H., Shimizu, H., et al. (2015) · Scientific Reports · doi:10.1038/srep17291 · Cited by 25
Human monoclonal antibodies that neutralize vaccine and wild-type poliovirus strains
Puligedda, R. D., Kouiavskaia, D. V., Adekar, S. P., Sharma, R., Kattala, C. D., Rezapkin, G. V., Bidzhieva, B., Dessain, S. K., & Chumakov, K. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.05.005 · Cited by 23
Comparison of poliovirus recombinants: accumulation of point mutations provides further advantages
Savolainen‐Kopra, C., Samoilovich, E., Kahelin, H., Hiekka, A., Hovi, T., & Roivainen, M. (2009) · Journal of General Virology · doi:10.1099/vir.0.010942-0 · Cited by 23
Adeniji, J. A., & Faleye, T. O. C. (2014) · Journal of Virological Methods · doi:10.1016/j.jviromet.2014.07.016 · Cited by 22
Farkas, K., Kevill, J. L., Williams, R. C., Pântea, I., Ridding, N., Lambert-Slosarska, K., Woodhall, N., Grimsley, J. M. S., Wade, M. J., Singer, A. C., et al. (2024) · FEMS Microbes · doi:10.1093/femsmc/xtae007 · Cited by 20
Amona, I., Medkour, H., Akiana, J., Davoust, B., Tall, M. L., Grimaldier, C., Gazin, C., Zandotti, C., Levasseur, A., Scola, B. L., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8111779 · Cited by 19
Zhao, K., Jorba, J. C., Shaw, J., Iber, J. C., Chen, Q., Bullard, K., Kew, O. M., & Burns, C. C. (2017) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2017.09.004 · Cited by 19
Sadeuh‐Mba, S. A., Kavunga‐Membo, H., Joffret, M., Riziki, Y., Endegue-Zanga, M. C., Bessaud, M., Njouom, R., Muyembé‐Tamfum, J., & Delpeyroux, F. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007335 · Cited by 18
Self-citationDefining the Enterovirus Diversity Landscape of a Fecal Sample: A Methodological Challenge?
Faleye, T. O. C., Adewumi, M. O., & Adeniji, J. A. (2016) · Viruses · doi:10.3390/v8010018 · Cited by 17
Limited and Localized Outbreak of Newly Emergent Type 2 Vaccine-Derived Poliovirus in Sichuan, China
Yan, D., Zhang, Y., Zhu, S., Chen, N., Li, X., Wang, D., Ma, X., Zhu, H., Tong, W., & Xu, W. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00196-14 · Cited by 17
Baba, M. M., Haruna, B. A., Ogunmola, O. P., Ambe, J. P., Shidali, N. N., Oderinde, B. S., Marcello, A., & Talle, M. A. (2012) · Journal of Medical Virology · doi:10.1002/jmv.23228 · Cited by 17
Razafindratsimandresy, R., Joffret, M., Andriamandimby, S. F., Andriamamonjy, S., Rabemanantsoa, S., Richard, V., Delpeyroux, F., Héraud, J., & Bessaud, M. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07826-0 · Cited by 15
Self-citationHigh frequency of enterovirus serotype circulation in a densely populated area of India
Kumar, A., Shukla, D., Srivastava, S., Idris, M. Z., & Dhole, T. N. (2013) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.2413 · Cited by 15
Poliopolis: Pushing Boundaries of Scientific Innovations for Disease Eradication
Damme, P. V., Coster, I. D., Bandyopadhyay, A. S., Suykens, L., Rüdelsheim, P., Neels, P., Oberste, M. S., Weldon, W. C., Clemens, R. L., & Revets, H. (2019) · Future Microbiology · doi:10.2217/fmb-2019-0196 · Cited by 15
Zhang, Y., Zhang, F., Zhu, S., Chen, L., Yan, D., Wang, D., Tang, R., Zhu, H., Hou, X., An, H., et al. (2009) · Archives of Virology · doi:10.1007/s00705-009-0564-9 · Cited by 15
Reemergence of Recombinant Vaccine–derived Polioviruses in Healthy Children, Madagascar
Razafindratsimandresy, R., Joffret, M.-L., Rabemanantsoa, S., Andriamamonjy, S., Heraud, J.-M., & Delpeyroux, F. (2013) · Emerging Infectious Diseases · doi:10.3201/eid1906.130080 · Cited by 14
Self-citationEmergence of Vaccine-Derived Polioviruses during Ebola Virus Disease Outbreak, Guinea, 2014–2015
Fernández-García, M. D., Majumdar, M., Kébé, O., Fall, A. D., Kone, M., Kande, M., Dabo, M., Sylla, M. S., Sompare, D., Howard, W., et al. (2017) · Emerging infectious diseases · doi:10.3201/eid2401.171174 · Cited by 14
Mapping Uncertainties in the Upstream: The Case of PLGA Nanoparticles in Salmon Vaccines
Nielsen, K. N., Fredriksen, B. N., & Myhr, A. I. (2011) · NanoEthics · doi:10.1007/s11569-011-0111-5 · Cited by 14
Wang, H.-B., Fang, G., Yu, W., Du, F., Fan, C., Liu, Q., Hao, L., Liu, Y., Zheng, J., Qin, Z.-Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113880 · Cited by 13
Sharif, S., Abbasi, B. H., Khurshid, A., Alam, M. M., Shaukat, S., Angez, M., Rana, M. S., & Zaidi, S. S. Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088442 · Cited by 12
Delpeyroux, F., Colbère-Garapin, F., Razafindratsimandresy, R., Sadeuh-Mba, S., Joffret, M.-L., Rousset, D., & Blondel, B. (2013) · médecine/sciences · doi:10.1051/medsci/20132911021 · Cited by 11
Self-citationSérémé, Y., Zarza, S. M., Medkour, H., Amona, I., Fenollar, F., Akiana, J., Mezouar, S., Orain, N., Vitte, J., Davoust, B., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9040810 · Cited by 11
Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria
Giwa, F. J., Olayinka, A., & Ogunsola, F. T. (2012) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.05.198 · Cited by 11
Polio, Still Lurking in the Shadows
van den Pol, A. N. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2861-12.2013 · Cited by 10
The Challenge of Achieving Immunity Through Multiple-Dose Vaccines in Madagascar
Jones, F. K., Mensah, K., Héraud, J., Randriatsarafara, F. M., Metcalf, C. J. E., & Wesolowski, A. (2021) · American Journal of Epidemiology · doi:10.1093/aje/kwab145 · Cited by 9
Ayukekbong, J. A., Fobisong, C., Lindh, M., Nkuo-Akenji, T., Bergström, T. B., & Norder, H. (2014) · Journal of Medical Virology · doi:10.1002/jmv.23926 · Cited by 9
Kew, O. M. (2014) · Springer eBooks · doi:10.1007/978-1-4899-7448-8_13 · Cited by 9
A severe case of co-infection with Enterovirus 71 and vaccine-derived Poliovirus type II
Ma, S., Du, Z.-Q., Feng, M. H., Che, Y., & Li, Q. (2015) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.08.017 · Cited by 8
Razafindratsimandresy, R., Mach, O., Héraud, J., Bernardson, B., Weldon, W. C., Oberste, M. S., & Sutter, R. W. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e00563 · Cited by 7
Wassilak, S. G. F., Mohamed, A., & Bigouette, J. P. (2025) · Vaccines · doi:10.3390/vaccines13101060 · Cited by 6
The Poliovirus Eradication Initiative
Chumakov, K., & Kew, O. M. (2014) · ASM Press eBooks · doi:10.1128/9781555816698.ch28 · Cited by 6
Poliovirus et entérovirus C, même espèce, même « tribu » virale
Andrianarivelo, M. R., Jégouic, S., Bessaud, M., & Delpeyroux, F. (2008) · médecine/sciences · doi:10.1051/medsci/2008245452 · Cited by 6
Self-citationRaharinantoanina, J., Joffret, M., Bessaud, M., Rakoto, D. A. D., Dussart, P., Lacoste, V., & Razafindratsimandresy, R. (2024) · Virology · doi:10.1016/j.virol.2024.110253 · Cited by 5
Liu, J., Zhang, H., Zhao, Y., Xia, L., Guo, C., Yang, H. F., Luo, N., He, Z., & Ma, S. (2016) · Virology Journal · doi:10.1186/s12985-016-0615-2 · Cited by 5
Shakaryan, A. K., Mikhailova, Y. M., Chirova, A. V., Cherepanova, E. A., Baikova, O. Y., Yakovchuk, E. V., Karpova, E. V., Ap, I., Skryabina, S. V., Snitkovskaya, T. E., et al. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70704 · Cited by 4
Estívariz, C. F., Burns, C. C., & Macklin, G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00050-5 · Cited by 4
Prevalence of vaccine-derived poliovirus in sewage waters in Maiduguri, Borno State, Nigeria
Bislava, S. B., Daja, A., Oderinde, B. S., & Uzairu, S. M. (2024) · Infezioni in Medicina · doi:10.53854/liim-3201-12 · Cited by 4
Poliovirus serotype 2 and coxsackievirus A promote the natural recombination of poliovirus
Qian, Y., Pu, X., Yu, Y., Yu, X., Kong, L., Liu, L., Wang, H. X., & Shen, H. (2019) · Journal of Medical Virology · doi:10.1002/jmv.25620 · Cited by 4
Dimitriou, T. G., Pliaka, V., Kyriakopoulou, Z., Ruether, I. G. A., Tsakogiannis, D., Fountoucidou, P., Gartzonika, C., Levidiotou-Stefanou, S., & Markoulatos, P. (2013) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2013.10.004 · Cited by 3
Fan, Q., Ma, J., Li, X., Jorba, J. C., Yuan, F., Zhu, H., Hu, L., Song, Y., Wang, D., Zhu, S., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28215 · Cited by 3
Fall, A., Morris, C. P., Elgazayerly, O., Wu, T., Abdullah, O. R., Norton, J. M., Pekosz, A. S., Klein, E., & Mostafa, H. H. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.01005-26 · Cited by 2
Evolution of targets at the host-pathogen interface
Beaudoin, C. A. (2023) · Apollo (University of Cambridge) · doi:10.17863/cam.109545 · Cited by 2
Wilton, T. (2012) · doi:10.25560/10677 · Cited by 1
Razafindratsimandresy, R., Joffret, M., Raharinantoanina, J., Polston, P. M., Andriamamonjy, S., Razanajatovo, I. M., Diop, O. M., Delpeyroux, F., Héraud, J., & Bessaud, M. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28071 · Cited by 1
Self-citationFall, A., Morris, C. P., Elgazayerly, O., Wu, A., Abdullah, O. R., Norton, J. M., Pekosz, A. S., Klein, E. Y., & Mostafa, H. H. (2025) · medRxiv · doi:10.1101/2025.11.22.25340766 · Cited by 1
Dimitriou, T. G., Kyriakopoulou, Z., Tsakogiannis, D., Fikatas, A., Gartzonika, C., Levidiotou-Stefanou, S., & Markoulatos, P. (2016) · Virus Genes · doi:10.1007/s11262-016-1333-y
Contribution of newly discovered and emerging viruses to human disease
Nguyen, D. V. (2016) · ERA
Fatiregun, A. A., Famiyesin, E., Bawa, S. B., & Ogunbodede, N. (2020) · Pan African Medical Journal · doi:10.11604/pamj.2020.37.6.17344
Current awareness: Pharmacoepidemiology and drug safety
(2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1491
Enteroviruses and Parechoviruses
Stellrecht, K. A., Lamson, D. M., & Romero, J. R. (2023) · Wiley eBooks · doi:10.1002/9781683674849.mcm0091
Enteroviruses and Parechoviruses
Stellrecht, K. A., Lamson, D. M., & Romero, J. R. (2023) · Wiley eBooks · doi:10.1002/9781683670438.mcm0091
Sauthier, J. T., Dias, J. B., Ferreira, C. D. S., Gomes, B. D. O. N., Fraga, K. A., Gonçalves, I. M. D. S., de Souza, A. A. A., dos Santos, A. A. C., Müller, B. D. L. A., Lima, L. F., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5180131
Bioinformatics and biostatistical studies of the mosaic structures of microbial genomes
Tall, M. L. (2020) · theses.fr (ABES) · doi:10.70675/fb252c16z71b2z4b3dza1ccza62d6af2142f
Medkour, H. (2020) · theses.fr (ABES) · doi:10.70675/58a94f04z314bz4dccz923dz78a302d8cca3
Placenta and infections : Coxiella burnetii and SARS-CoV-2
Zarza, S. M. (2022) · theses.fr (ABES) · doi:10.70675/423df3fez00c0z48acz9a6bz7cf26b598c75
Metadata
- Authors
- Rakoto‐Andrianarivelo, M., Gumede, N., Jegouic, S., Balanant, J., Andriamamonjy, S. N., Rabemanantsoa, S., Birmingham, M., Randriamanalina, B., Nkolomoni, L., Venter, M., Schoub, B. D., Delpeyroux, F., & Reynes, J.
- Affiliations
- National Institute for Communicable Diseases (ZA)
- Institut Pasteur (FR)
- Institut Pasteur de Madagascar (MG)
- World Health Organization (CH)
- Ministry of Public Health (MG)
- University of Pretoria (ZA)
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-05-15
- Volume
- 197
- Issue
- 10
- Pages
- 1427-1435
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2116699880
- Cited by
- 100
- References
- 30
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 4 · 2021: 3 · 2020: 4 · 2019: 4 · 2018: 2 · 2017: 4 · 2016: 5 · 2015: 4 · 2014: 12 · 2013: 11 · 2012: 9
- FWCI
- 5.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- UpSpace Institutional Repository (University of Pretoria) (submittedVersion)
- Funders
- World Health Organization
- Centre National de la Recherche Scientifique
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Keywords
- vaccine-derived poliovirus, poliovirus outbreak, acute flaccid paralysis, co-circulation, vaccination coverage, Toliara Province, Madagascar, polio surveillance
- MeSH terms
- Child, Preschool, Disease Outbreaks, Humans, Madagascar, Male, Phylogeny, Poliomyelitis, Recombination, Genetic, RNA, Viral, Vaccines, Synthetic, Sequence Analysis, DNA, Poliovirus, Poliovirus Vaccines, Enterovirus C, Human
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.